Susvimo is an FDA-approved eye implant for diabetic macular edema that may reduce monthly injections to just two treatments a year while maintaining vision outcomes.
Why CASA Therapy’s Expansion Matters for Couples and Individuals in Irvine, CA Irvine, United States - March 9, 2026 / ...
Company launched TONMYA, approved by the FDA as a treatment for fibromyalgia, in November 2025 In post hoc analysis of the pivotal RESILIENT study, TONMYA produced rapid pain relief as early as Day 2 ...
13h
FMUSER Invites System Integrators to Test Hardcore CAT6 Hotel IPTV Solution During 2026 Canton Fair
Discover how the FMUSER LAN-based smart hotel IPTV system solves signal instability. Test the physical hardware just 30 ...
DONGGUAN, GUANGDONG, CHINA, March 10, 2026 /EINPresswire.com/ -- The rapid expansion of smart city infrastructure has ...
TONMYA (cyclobenzaprine HCl sublingual tablets) for the treatment of fibromyalgia in adults, was commercially launched in November 2025 Treatment with TONMYA provided statistically significant pain ...
Approval based on unprecedented Phase 3 data demonstrating statistically significant improvements in progression-free survival and overall survival versus standard of care regimens83.3% of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results